Circular RNA (circRNA) is a class of non-coding RNA molecules without a 5' terminal cap and a 3' terminal poly(A) tail, and form a ring structure by covalent bonding, which are objectively present in organisms, and are significantly different from linear RNAs. Discovered in 1976, the circRNA molecule was once ignored as 'junk' after RNA splicing. However, after more than 30 years of inactivity, circRNAs burst onto the scene in 2013 and have become important candidates for the development of next-generation RNA therapeutics.
Figure.1 Three types of circular RNA. (L, P, Qiu.; et al, 2018)
circRNAs can be categorized into exonic circRNAs, retained-intron circRNAs, and circular intronic RNAs according to their origin. circRNAs are formed differently from the standard shearing model of linear RNAs, which are sheared by backsplicing. There are five main existing models of circRNA formation as follows:
circRNAs were once thought to be errors in the normal splicing process. In recent years, there has been an explosion of circRNA-related research. circRNAs have been found to be important players in normal cellular differentiation and tissue homeostasis as well as in disease development, and the expression of circRNAs is usually not correlated with host gene expression. This suggests that circRNAs are not merely homeostatic byproducts of mRNA splicing, but rather products of novel regulated variable splicing. Sequence conservation analysis also demonstrated that circRNAs have important noncoding functions.
Figure 2. Metabolism of circRNA. (W, Y, Zhou .; et al, 2020)
circRNAs contain a large number of miRNA binding sites and act as miRNA sponges, which in turn indirectly regulate the expression of miRNA downstream target genes. For example, ciRS7, the first circRNA revealed to have a regulatory function, acts as a sponge for miR7 and contains 470 conserved binding sites for miR7. ciRS7 is stably expressed in many tissues of the human body, and increases the expression level of miR7 target genes by inhibiting miR7 activity. And miR7 directly targets several oncogenes involved in many different human cancers.
Some circular RNAs have one or more binding sites for RNA-binding proteins and can act as sponges for protein molecules.
Some endogenous circular RNAs play a role in the antiviral response, while others are associated with immune response. Exogenous cyclic RNAs can stimulate immune signaling in mammalian cells by activating the pattern recognition receptor RIG-I.
Although circRNAs are non-coding RNAs, there are a few circRNAs that can encode polypeptides, through which they exercise regulatory functions.
A CRISPR-Cas13d-based screening tool, CRISPR-RfxCas13d, has been researched and developed to enable rapid screening and discovery of functional circRNAs.This screening tool targets the reverse splicing site of circRNAs through gRNAs Based on this technology, the research team constructed a lentiviral library targeting the reverse splice site sequences of highly expressed human circRNAs, and using this screening library, the team identified a set of functional circRNAs that are important for cell growth and embryonic development.
The study identifies a mitochondria-specific circRNA, SCAR, whose expression is down-regulated in non-alcoholic steatohepatitis (NASH). Delivering SCAR specifically to mitochondria reduces mitochondrial reactive oxygen species (mROS) output and reduces inflammation, and could be a therapeutic target for non-alcoholic steatohepatitis (NASH). therapeutic target.
The study describes an in vivo specific knockdown of circRNAs at tissue and cellular resolution, utilizing shRNAs targeted to circRNA-specific reverse splice sites to specifically knock down circRNAs with no off-target effects.
References